#moderna

[ follow ]
#mrna-technology
Coronavirus
fromArs Technica
1 week ago

RFK Jr. yanks pandemic vaccine funding as Moderna reports positive results

The HHS canceled funding for Moderna's mRNA flu vaccine due to safety concerns and the need for more testing.
fromMedCity News
1 week ago
Coronavirus

Bird Flu Threat Still Looms, But HHS Just Canceled a Moderna Contract That Could Prepare for It - MedCity News

Coronavirus
fromArs Technica
1 week ago

RFK Jr. yanks pandemic vaccine funding as Moderna reports positive results

The HHS canceled funding for Moderna's mRNA flu vaccine due to safety concerns and the need for more testing.
fromMedCity News
1 week ago
Coronavirus

Bird Flu Threat Still Looms, But HHS Just Canceled a Moderna Contract That Could Prepare for It - MedCity News

more#mrna-technology
#covid-19
Coronavirus
fromCbsnews
1 week ago

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

A new COVID-19 vaccine from Moderna offers a lower dose and targets those at high risk, reflecting changes in vaccination policy.
Coronavirus
fromCbsnews
1 week ago

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

A new COVID-19 vaccine from Moderna offers a lower dose and targets those at high risk, reflecting changes in vaccination policy.
more#covid-19
#vaccine-development
Public health
fromABC7 San Francisco
11 months ago

The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine

The U.S. government is funding Moderna to expedite pandemic influenza vaccine development, adaptable to different strains of influenza.
Public health
fromABC7 San Francisco
11 months ago

The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine

The U.S. government is funding Moderna to expedite pandemic influenza vaccine development, adaptable to different strains of influenza.
more#vaccine-development
Coronavirus
fromABC7 San Francisco
11 months ago

Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial

Moderna's combo flu and COVID vaccine generates a strong immune response in older adults, potentially offering a promising solution in combating respiratory illnesses.
[ Load more ]